Lixivaptan &Ndash; An Evidence-Based Review of Its Clinical Potential in the Treatment of Hyponatremia

Core Evidence - New Zealand
doi 10.2147/ce.s36744
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Lixivaptan and Hyponatremia

Kidney International
Nephrology
2013English

Palbociclib: An Evidence-Based Review of Its Potential in the Treatment of Breast Cancer

Breast Cancer: Targets and Therapy
Oncology
2014English

Capecitabine: An Evidence-Based Review of Its Effectiveness in the Treatment of Carcinoma of the Pancreas

Core Evidence
MedicineReviewsReferencesPharmacology
2007English

Review of Tolvaptan in the Treatment of Hyponatremia

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2011English

Tadalafil: The Evidence for Its Clinical Potential in the Treatment of Pulmonary Arterial Hypertension

Core Evidence
MedicineReviewsReferencesPharmacology
2007English

Alemtuzumab: Evidence for Its Potential in Relapsing–remitting Multiple Sclerosis

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2013English

An Evidence-Based Review of Fremanezumab for the Treatment of Migraine

Pain and Therapy
NeurologyAnesthesiologyPain Medicine
2020English

Conivaptan: Evidence Supporting Its Therapeutic Use in Hyponatremia

Core Evidence
MedicineReviewsReferencesPharmacology
2009English

Lurasidone for the Treatment of Bipolar Depression: An Evidence-Based Review

Neuropsychiatric Disease and Treatment
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy